Wednesday, August 5, 2020

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/33rS6b3

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...